Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Palladium Catalyzed Substitution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed method for Z-allyl amino acids via azlactones. High stereoselectivity, mild conditions. Ideal for reliable pharmaceutical intermediate supplier needs.
Patent CN1291609A reveals a robust solid-base process for 5-lipoxygenase inhibitors. Achieve high purity and cost reduction in API manufacturing with scalable methods.
Novel Pd-catalyzed allylic substitution for high-purity trifluoromethyl olefins. Superior E/Z selectivity and scalable process for pharma intermediates.
Patent CN115197161B details novel palladium catalysis for Z-configuration amino acids. Enables cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102399163B reveals a high-yield 4-step route to Chloramphenicol using 4-chlorobenzaldehyde, eliminating resolution and reducing waste for reliable API intermediate supply.
Novel biaryl ligand synthesis via Catellani reaction offers high enantioselectivity and scalable routes for pharmaceutical intermediates.
Patent CN111718372B discloses a novel axial chiral ligand enabling high-yield asymmetric allylic substitution with simplified synthesis for cost-effective API manufacturing.
Patent CN111718372B discloses a novel axial chiral ligand enabling high-yield asymmetric allylic substitution with excellent enantioselectivity for cost-effective API manufacturing.
Patent CN114369045B details a Pd-catalyzed route to fluorine-containing olefins. Offers mild conditions and high yields for API intermediates.
Patent CN114369045B details a Pd-catalyzed route to fluorinated olefins. Offers high yield and mild conditions for pharma intermediates.
Patent CN114369045B discloses a novel Pd-catalyzed synthesis of fluorine-containing alkylthio olefins using alkenyl sulfonium salts, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN111718372B enables high-purity fine chemical production through innovative ligand technology with reduced lead time and scalable manufacturing solutions for pharmaceutical intermediates.
Discover a scalable Pd-catalyzed route for trifluoromethyl-chromone quinolines with 90%+ yields. Eliminate expensive pre-activation and harsh conditions. Reduce supply chain risks for your API synthesis.